Jeffrey Frankel
Burien, WANPI 1487694154
Payments from drug & device makers
$514,617in general payments, 2019–2025
Across 550 payments — averaging $935.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$215K
- Myovant Sciences Inc.$65K
- Astellas Pharma US Inc$56K
- Astellas Pharma Global Development$46K
- Ferring Pharmaceuticals AS$29K
- Pfizer$25K
- plus $79K from 30 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 164 | $214,534 |
| Myovant Sciences Inc. | 46 | $65,357 |
| Astellas Pharma US Inc | 76 | $55,745 |
| Astellas Pharma Global Development | 15 | $46,408 |
| Ferring Pharmaceuticals AS | 16 | $28,777 |
| Pfizer | 37 | $25,207 |
| Janssen Research & Development, LLC | 27 | $21,912 |
| Tolmar Pharmaceuticals, Inc. | 10 | $17,407 |
| Ferring International Pharmascience Center US | 8 | $16,309 |
| Urovant Sciences Inc | 17 | $12,723 |
| AstraZeneca | 6 | $3,443 |
| Myovant Sciences GmbH | 8 | $1,531 |
| Janssen Scientific Affairs, LLC | 5 | $834 |
| Dendreon Pharmaceuticals LLC | 14 | $477 |
| Ferring Pharmaceuticals Inc. | 13 | $451 |
| Johnson & Johnson | 15 | $407 |
| Verathon Inc. | 1 | $400 |
| AbbVie | 13 | $355 |
| Progenics Pharmaceuticals, Inc. | 4 | $354 |
| Amgen | 7 | $255 |
| Bayer | 9 | $244 |
| Boston Scientific | 3 | $193 |
| Teleflex LLC | 3 | $176 |
| Immunitybio, Inc. | 1 | $162 |
| Coloplast | 7 | $161 |
| Astellas Pharma Inc | 1 | $141 |
| Convatec Inc. | 4 | $118 |
| 180 Medical, Inc. | 3 | $97 |
| Myriad Genetic Laboratories, Inc. | 5 | $95 |
| Dentsply IH Inc. | 4 | $88 |
| Merck | 1 | $87 |
| Rochester Medical Corporation | 3 | $58 |
| Axonics, Inc. | 1 | $35 |
| Verity Pharmaceuticals Inc. | 1 | $34 |
| Urogen Pharma, Inc. | 1 | $25 |
| Laborie Medical Technologies Corp. | 1 | $16 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.